HDAC9 and acute kidney injury: Furthermore, because epigenetic changes are also observed in AKI, and histone deacetylase (HDAC) inhibitors might protect from kidney injury (Van Beneden et al., 2011, , 2013), we further hypothesized that histone lysine crotonylation might be a contributor to and a therapeutic target in AKI.